The post-JXX costs environment

Long credit has a cost. The question is whether that cost is visible, recoverable and safe on assessment. Our model is for firms who would rather have a transparent, defensible invoice than a bundled finance arrangement that may leave a shortfall later.

The market used to bundle three things together: expert evidence, administration, and finance. JXX separates the question: what is the reasonable recoverable cost of obtaining the report? MedMost is built for that new world.

We provide the report transparently; finance, if needed, is separately documented.

Questions you should ask an MRO:

• Will you give us the expert’s original fee note?

• Is your admin charge separately stated?

• Is your MRO charge 25% or less of the expert fee?

• Who absorbs any shortfall if the paying party challenges the fee?

• Are credit/write-off terms funded by higher charges?

• Can the invoice be explained easily on assessment?

• Is the client exposed to any unrecovered balance?

MedMost is the transparent MRO for the post-JXX market: original expert fee note supplied, administration charge separately stated, and no more than 25% of the expert’s fee.

Long credit is not free.  It is either priced into the report, challenged on assessment, or paid by someone later. MedMost keeps the cost visible from the start.